Drug to treat canine lymphoma gets FDA approvalJanuary 3, 2017VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.
SPONSORED CONTENTScience In Every StepFeel confident knowing every step a Librela (bedinvetmab injection) treated dog takes is backed by science + Learn More
